1FURLAN M,ROBLES R,GALBUSERA M,et al.von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome[J].N Engl J Med,1998,339:1578-1584.
2TSAI H M,LIAN E C.Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura[J].N Engl J Med,1998,339:1585-1594.
3FUJIKAWA K,SUZUKI H,MCMULLEN B,et al.Purification of human von Willebrand factor-cleaving protease and its identification as a new member of the metalloproteinase family[J].Blood,2001,98:1662-1666.
4GERRITSEN H E,ROBLES R,LAMMLE B,et al.Partial amino acid sequence of purified von Willebrand factor-cleaving protease[J].Blood,2001,98:1654-1661.
5ZHENG X,CHUNG D,TAKAYAMA T K,et al.Structure of von Willebrand factor-cleaving protease (ADAMTS13),a metalloprotease involved in thrombotic thrombocytopenic purpura[J].J Biol Chem,2001,276:41059-41063.
6ZHOU W,INADA M,LEE T P,et al.ADAMTS13 is expressed in hepatic stellate cells[J].Lab Invest,2005,85:780-788.
7SUZUKI M,MURATA M,MATSUBARA Y,et al.Detection of von Willebrand factor-cleaving protease (ADAMTS-13) in human platelets[J].Biochem Biophys Res Commun,2004,313:212-216.
8MORIGUCHI-GOTO S,YAMASHITA A,TAMURA N,et al.ADAMTS-13 attenuates thrombus formation on type I collagen surface and disrupted plaques under flow conditions[J].Atherosclerosis,2009,203:409-416.
9SOEJIMA K,NAKAMURA H,HIRASHIMA M,et al.Analysis on the molecular species and concentration of circulating ADAMTS13 in Blood[J].J Biochem,2006,139:147-154.
10CHAUHAN A K,KISUCKA J,BRILL A,et al.ADAMTS13:a new link between thrombosis and inflammation[J].J Exp Med,2008,205:2065-2074.
5COPPOLA G,RIZZO M,ABRIGNANI M G,et al.Fibrinogen as a predictor of mortality after acute myocardial infarction:a forty-two-month follow-up study[J].Ital Heart J,2005,6:315-322.
6ITAKURA H,SOBEL B E,BOOTHROYD D,et al.Do plasma biomarkers of coagulation and fibrinolysis differ between patients who have experienced an acute myocardial infarction versus stable exertional angina?[J].Am Heart J,2007,154:1059-1064.
7BAYES-GENIS A,MATEO J,SANTALO M,et al.D-Dimer is an early diagnostic marker of coronary ischemia in patients with chest pain[J].Am Heart J,2000,140:379-384.
3Gawaz M. Role of platelets in coronary thrombosis and reperfusion of ischemic myocardium[J].Cardiovasc Res, 2004,61(3) :498-511.
4Gyongyosi M, Glograr D, Weidinger F, et al. Association between plasmin activation system and intravascular ul- trasound signs of plaque instability in patiens with unstable angina and non-st-segment elevation myocardial infarction [J].Am Heart J, 2004,147(1 ) : 158-164.
5GOTO S, TAMURA N, ISHIDA H. Ability of anti- glycoprotein lI b/Ill a agents to dissolve platelet thrombi formed on a collagen surface under blood flow conditions [J] J Am Coll Cardiol, 2004,44 : 316 - 323.
6CANDEMIR B, KILICKAP M, OZCAN O U, et al. Intraeoronary versus intravenous high-dose bolus plusmaintenance administration of tirofiban in patients un- dergoing primary percutaneous coronary intervention for acute ST elevation myocardial infarction [J]. J Thromb Thrombolysis, 2012,34 : 65 - 72.
7ERDIM R, ERCIYES D, GORMEZ S, et al. Compari- son of intracoronary versus intravenous administration of tirofiban in primary percutaneous coronary intervention [J] Anadolu Kardiyol Derg, 2010,10 : 340- 345.
8DAVIES M J. Stability and instability: two faces of coronary atherosclerosis. The Paul Dudley White Lec- ture 1995 [J]. Circulation, 1996,94 : 2013 - 2020.
9HORII M, UEMURA S, UEMURA M, et al. Acute myocardial infarction as a systemic prothrombotic con- dition evidenced by increased yon Willebrand factor protein over ADAMTS13 activity in coronary and sys- temic circulation[J]. Heart Vessels, 2008,23:301- 307.
10NARDONE R, DE BLASI P, SEIDL M, et al. Cog- nitive function and cholinergic transmission in patients with subcortical vascular dementia and microbleeds: a TMSstudy[J]. J Neural Transm, 2011,118 :1349 - 1358.
